Skip to main content

Table 2 Plasma concentrations of miR-331-3p and miR-23b-3p in group II (n = 50)

From: The expression of microRNA-331-3p and microRNA-23b3 in Egyptian patients with early-stage hepatocellular carcinoma in hepatitis C-related liver cirrhosis

  BCLC stage U p
Stage 0 (n = 16) Stage A (n = 34)
miR-331-3p (2−∆CT)
 Mean ± SD 8.1 ± 10.3 7.3 ± 10.1 270.0 0.967
 Median (min.–max.) 3.8 (1.3–36.2) 3.7 (0.1–41)
miR-23b-3p (2−∆CT)
 Mean ± SD 0.21 ± 0.22 0.31 ± 0.37 229.0 0.371
 Median (min.–max.) 0.14 (0.01–0.8) 0.18 (0.02–1.7)
  1. U Mann-Whitney test, p p value for comparing between BCLC stage and serum concentrations of miR-331-3p and miR-23b-3p